Skip to main content

Australia’s active vaccine safety system

Secondary Menu

  • Contact
  • About us
  • Vaccine safety surveillance
    • How vaccine safety surveillance works
    • How AusVaxSafety works
    • Information for immunisation providers
    • Information for immunisation recipients
    • Publications
  • Vaccine safety data
    • COVID-19 vaccines
    • Influenza vaccines
    • Mpox (monkeypox) vaccine
    • National Immunisation Program schedule vaccines
    • Nirsevimab
    • Vaccine safety in Australia AusVaxSafety summary reports
  • News & events
  • Resources
  • Contact

Main navigation

  • About us
  • Vaccine safety surveillance
    • How vaccine safety surveillance works
    • How AusVaxSafety works
    • Information for immunisation providers
    • Information for immunisation recipients
    • Publications
  • Vaccine safety data
    • COVID-19 vaccines
    • Influenza vaccines
    • Mpox (monkeypox) vaccine
    • National Immunisation Program schedule vaccines
    • Nirsevimab
    • Vaccine safety in Australia AusVaxSafety summary reports
    • News & events
    • Resources
    News & events
    21 May 2026 | News
    Australia’s first real-world safety data confirm nasal spray influenza vaccine is well-tolerated by children and adolescents
    02 April 2026 | News
    AusVaxSafety begins surveillance of 2026 influenza vaccines, including new nasal spray option
    05 March 2026 | News
    New LP.8.1 COVID-19 vaccines well tolerated, new AusVaxSafety data show
    14 July 2025 | News
    Fewer adverse events reported following NIP pneumococcal vaccine change
    03 June 2025 | News
    New AusVaxSafety data confirms Abrysvo RSV vaccine is well tolerated during pregnancy; adverse events comparable to other maternal vaccinations
    18 May 2025 | News
    2025 Australian flu season: Who should get a flu shot, which vaccines are available and what to expect in the days following your vaccination
    31 March 2025 | News
    AusVaxSafety commences routine surveillance of 2025 seasonal influenza vaccines
    10 March 2025 | News
    New JN.1 COVID-19 vaccines well tolerated, AusVaxSafety data show
    06 March 2025 | News
    AusVaxSafety publishes Australian-first safety data for Arexvy RSV vaccine
    08 January 2025 | News
    New report re-affirms short-term safety of vaccines in Australia
    All news & events
    Tue, 01/17/2017 | News

    The backstory to a landmark development for vaccine safety

     Access the full Croakey article here.

    Share this article:

    Navigate

    • Contact Us
    • Disclaimer
    • Privacy
    • Accessibility

    AusVaxSafety receives funding
    from the Australian Government

    NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

    We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

    Copyright © 2026 AusVaxSafety. All rights reserved

    vaccine

    Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

    Subscribe to our newsletter for immunisation professionals

    Stay updated with the latest from NCIRS

     
    • Contact Us
    • Disclaimer
    • Privacy
    • Accessibility
    Subscribe to our newsletter for immunisation professionals

    Stay updated with the latest from ausvax

     

    NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

    Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

    We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.